Synergistic Minimally Invasive Surgery and Deferoxamine in ICH

Summary

This is a multicenter, randomized, open-label trial designed to evaluate the safety, feasibility, and efficacy of combining minimally invasive surgery (MIS) with intravenous deferoxamine (DFX) for the treatment of spontaneous intracerebral hemorrhage (ICH), compared to standard medical care. This trial represents the first investigation of a dual-modality approach in ICH, integrating mechanical clot evacuation with biochemical neuroprotection, with the goal of improving neurological outcomes.

Timeline

Start

2026-03-01

Primary completion

2028-12-30

Completion

2028-12-30

Drugs

Indications